Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05824338Phase 1Recruiting
Phase 1, randomised trial of ropivacaine in Anesthesia (3 arms), sponsored by Fraser Health. Primary endpoints: Acceptability of study procedures and intervention: eligibility and recruitment, Acceptability of study procedures and intervention: attrition and 1 more. Started Aug 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05824338.